Matrix Metalloproteinase 10 Contributes to Choroidal Neovascularisation

Area of Science:

• Ophthalmology
• Molecular Biology
• Cell Biology

Background:

• Age-related macular degeneration (AMD) is a leading cause of vision loss in developed countries.
• Oxidative stress and matrix metalloproteinases (MMPs) are implicated in AMD pathogenesis, particularly neovascular AMD.
• Understanding the specific role of MMPs in choroidal neovascularisation (CNV) is crucial for therapeutic development.

Purpose of the Study:

• To investigate the role of matrix metalloproteinase-10 (MMP10) in the development of choroidal neovascularisation (CNV).

Main Methods:

• Assessed MMP10 expression in retinal pigment epithelium and endothelial cells using cell culture, mouse, and human retinal samples.
• Examined MMP10 expression and activity under oxidative stress conditions in ARPE-19 cells.
• Evaluated CNV size in MMP10 knockout (MMP10-/-) mice and measured plasma MMP10 levels in neovascular AMD patients versus controls.

Main Results:

• MMP10 was expressed by retinal pigment epithelium and neovascular endothelial cells.
• MMP10 expression and activity were upregulated by oxidative stress in ARPE-19 cells.
• MMP10-/- mice exhibited reduced laser-induced CNV areas, and plasma MMP10 levels did not differ between AMD patients and controls, indicating local MMP10 involvement.

Conclusions:

• MMP10 is locally expressed and actively involved in the development of choroidal neovascularisation.
• MMP10 emerges as a potential therapeutic target for managing neovascular AMD.